Susan's Place Logo

News:

Based on internal web log processing I show 3,417,511 Users made 5,324,115 Visits Accounting for 199,729,420 pageviews and 8.954.49 TB of data transfer for 2017, all on a little over $2,000 per month.

Help support this website by Donating or Subscribing! (Updated)

Main Menu

Androgen therapy may slow progress of Alzheimer's disease

Started by LostInTime, December 20, 2006, 11:13:31 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

LostInTime

Link

The research team established a correlation between low testosterone and elevated beta-amyloid (Aâ), a protein that accumulates abnormally in Alzheimer's disease patients. This finding, they say, suggests that testosterone depletion in aging men may be a risk factor for AD by promoting accumulation of Aâ in the brain. Testosterone, the primary male sex hormone, is one in a group of related steroid hormones referred to as androgens. Recent studies suggest that androgens may lower Aâ levels.

  •